Epidemiology of heart failure in young adults: a French nationwide cohort study
- PMID: 36452998
- PMCID: PMC9890267
- DOI: 10.1093/eurheartj/ehac651
Epidemiology of heart failure in young adults: a French nationwide cohort study
Erratum in
-
Correction to: Epidemiology of heart failure in young adults: a French nationwide cohort study.Eur Heart J. 2024 Jul 9;45(26):2335. doi: 10.1093/eurheartj/ehae187. Eur Heart J. 2024. PMID: 38833330 Free PMC article. No abstract available.
Abstract
Aims: Heart failure (HF) in young adults is uncommon, and changes in its incidence and prognosis in recent years are poorly described.
Methods and results: The incidence and prognosis of HF in young adults (1850 years) were characterized using nationwide medico-administrative data from the French National Hospitalization Database (period 20132018). A total of 1,486 877 patients hospitalized for incident HF were identified, including 70 075 (4.7) patients aged 1850 years (estimated incidence of 0.44 for this age group). During the study period, the overall incidence of HF tended to decrease in the overall population but significantly increased by 0.041 in young adults (P 0.001). This increase was notably observed among young men (from 0.51 to 0.59, P 0.001), particularly those aged 3650 years. In these young men, ischaemic heart disease (IHD) was the most frequently reported cause of HF, whereas non-ischaemic HF was mainly observed in patients 35 years old. In contrast to non-ischaemic HF, the incidence of IHD increased over the study period, which suggests that IHD-related HF is progressively affecting younger patients. Concordantly, young HF patients presented with high rates of traditional IHD risk factors, including obesity, smoking, hypertension, dyslipidaemia, or diabetes. Lastly, the rates of re-hospitalization (for HF or for any cause) within two years after the first HF event and in-hospital mortality were high in all groups, indicating a poor-prognosis population.
Conclusion: Strategies for the prevention of HF risk factors should be strongly considered for patients under 50 years old.
Keywords: Epidemiology; Heart failure; Ischaemia; Risk factors; Young people.
The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: The APHP, which employs Pr. J.-S.H., has received research grants from Bioserenity, Pliant Thx, Sanofi, Servier, and Novo Nordisk. He has also received speaker, advisory board, or consultancy fees from Alnylam, Amgen, Astra Zeneca, Bayer, Bioserenity, Boerhinger Ingelheim, MSD, Novartis, Novo Nordisk, and Vifor Pharma, all unrelated to the present work. Other authors declare no competing financial interests.
Figures




Comment in
-
Increasing incidence of heart failure among young adults: how can we stop it?Eur Heart J. 2023 Feb 1;44(5):393-395. doi: 10.1093/eurheartj/ehac730. Eur Heart J. 2023. PMID: 36537120 No abstract available.
References
-
- Roberts NL, Mountjoy-Venning WC, Anjomshoa M, Banoub JAM, Yasin YJGBD. 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study (vol 392, pg 1789, 2018). Lancet 2019;393:E44–E44. 10.1016/S0140-6736(19)31429-1 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous